 Livemint | India revokes patent for Pfizer's Sutent Livemint Cipla and a few other local drug makers, including Natco Pharma Ltd, had opposed the Indian patent for Sutent, a liver and kidney cancer drug sold by Pfizer worldwide. The drug, known as Sunitinib in generic terms, was developed by US drug makers Sugen ... |
